NLS Pharmaceutics AG (NLSP) — Net Asset Momentum
NLS Pharmaceutics AG (NLSP) recorded a net asset momentum of 115.9% as of December 2024, with net assets of $1.41 Million USD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See net assets of NLS Pharmaceutics AG for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
NLS Pharmaceutics AG Net Asset Momentum (2017–2024)
This chart tracks NLS Pharmaceutics AG's year-over-year net asset growth across 8 annual reporting periods from 2017 to 2024. The most recent momentum reading is +115.9%, with net assets of $1.41 Million USD as of December 2024. For live market cap and overall valuation, see market cap of NLS Pharmaceutics AG.
Annual Net Asset History for NLS Pharmaceutics AG (2017–2024)
The table below shows the complete annual net asset history for NLS Pharmaceutics AG from 2017 to 2024, covering 8 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. Check NLSP tangible net worth ratio to evaluate the tangible quality of the company's equity base.
| Year | Net Assets (USD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | $1.41 Million | $2.23 Million | $826.76K | ▲ +115.9% |
| 2023 | $-8.83 Million | $1.85 Million | $10.68 Million | ▼ -369.2% |
| 2022 | $3.28 Million | $9.28 Million | $6.00 Million | ▲ +504.9% |
| 2021 | $542.39K | $5.76 Million | $5.22 Million | ▲ +106.0% |
| 2020 | $-8.98 Million | $1.21 Million | $10.20 Million | ▼ -45.6% |
| 2019 | $-6.17 Million | $696.43K | $6.87 Million | ▲ +30.0% |
| 2018 | $-8.81 Million | $145.63K | $8.96 Million | ▼ -14.2% |
| 2017 | $-7.72 Million | $2.29 Million | $10.01 Million | — |